Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Schipper

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular CarcinomaDaniel J Herr, Chang Wang, Mishal Mendiratta-Lala, et al.
Medical Physics|August 26, 2018
Machine learning and modeling: Data, validation, communication challengesIssam El Naqa, Dan Ruan, Gilmer Valdes, et al.
Advances in Radiation Oncology|November 29, 2024
Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality ConsortiumSamuel N Regan, Michael Dykstra, Huiying Yin, et al.
BMJ (Clinical Research Ed.)|February 8, 2022
Early phase clinical trials extension to guidelines for the content of statistical analysis plansVictoria Homer, Christina Yap, Simon Bond, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
JCO Oncology Practice|September 26, 2025
Androgen Deprivation Therapy Practice Patterns in High-Risk Prostate Cancer Treated With Definitive Radiotherapy: Prospective Results From a Statewide Quality ConsortiumMichael P Dykstra, Samuel N Regan, Huiying Maggie Yin, et al.
Cancer|October 18, 2025
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survivalKemal Caglar Gogebakan, Zizi Elsisi, Felipe Montano-Campos, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradationShirish Shukla, Uday Sankar Allam, Aarif Ahsan, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2023
A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular CarcinomaDaniel J Herr, Chang Wang, Mishal Mendiratta-Lala, et al.
Medical Physics|August 26, 2018
Machine learning and modeling: Data, validation, communication challengesIssam El Naqa, Dan Ruan, Gilmer Valdes, et al.
Advances in Radiation Oncology|November 29, 2024
Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality ConsortiumSamuel N Regan, Michael Dykstra, Huiying Yin, et al.
BMJ (Clinical Research Ed.)|February 8, 2022
Early phase clinical trials extension to guidelines for the content of statistical analysis plansVictoria Homer, Christina Yap, Simon Bond, et al.
Cancer Medicine|November 7, 2024
Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare SystemSean R Miller, Matthew Schipper, Lars G Fritsche, et al.
JCO Oncology Practice|September 26, 2025
Androgen Deprivation Therapy Practice Patterns in High-Risk Prostate Cancer Treated With Definitive Radiotherapy: Prospective Results From a Statewide Quality ConsortiumMichael P Dykstra, Samuel N Regan, Huiying Maggie Yin, et al.
Cancer|October 18, 2025
Prostate-specific membrane antigen positron emission tomography/computed tomography imaging as a precision diagnostic at prostate cancer recurrence after radical prostatectomy: Modeling long-term survivalKemal Caglar Gogebakan, Zizi Elsisi, Felipe Montano-Campos, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradationShirish Shukla, Uday Sankar Allam, Aarif Ahsan, et al.
Cancer Medicine|June 20, 2024
Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advancesAlex K Bryant, Rafael Zamora-Resendiz, Xin Dai, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
Pageof 9